Table 3.

Characteristics of study population by LVH status (n = 366)

CharacteristicNo LVH (n = 305)LVH (n = 61)P
Black race (n [%])44 (15)15 (25)0.051
Female gender (n [%])114 (37)32 (53)0.028
Age (yr)
    <6 (n [%])38 (13)13 (21)0.068
    median (IQR)12 (9 to 16)11 (6 to 15)0.067
Height (cm)
    median (IQR)146 (126 to 162)135 (111 to 153)0.006
    percentile (median [IQR])27.0 (10.0 to 51.0)7.7 (2.0 to 29.0)<0.001
Weight (kg)
    median (IQR)41 (27 to 57)34 (20 to 53)0.066
    percentile (median [IQR])43 (19 to 75)41 (12 to 65)0.261
BMI percentile (median [IQR])57 (32 to 84)69 (45 to 90)0.12
Duration of CKD (yr; median [IQR])8.1 (4.5 to 11.7)5.8 (3.0 to 9.4)0.002
Glomerular CKD (n [%])58 (19)14 (23)0.46
Iohexol GFR (ml/min per 1.73 m2; median [IQR])43 (32 to 55)41 (27 to 49)0.11
Hypoalbuminemia <4 g/dl (n [%])33 (11)12 (21)0.046
Protein/creatinine ratio (median [IQR])0.43 (0.17 to 1.11)0.64 (0.28 to 2.10)0.014
Nephrotic proteinuria, >2 protein/creatinine ratio (n [%])30 (10)14 (26)0.002
Hemoglobin (g/dl; median [IQR])13 (12 to 14)12 (11 to 13)0.003
Anemia (n [%])114 (39)32 (53)0.048
wide range C-reactive protein (wrCRP) >0.3 mg/dl (n [%])105 (43)21 (40)0.76
Albumin-corrected calcium (mg/dl; median [IQR])9.0 (8.8 to 9.2)9.0 (8.7 to 9.3)0.94
Phosphate (mg/dl; median [IQR])4.7 (4.2 to 5.2)4.7 (4.2 to 5.4)0.42
Calcium × phosphate (mg2/dl2; median [IQR])42 (37 to 47)43 (37 to 48)0.32
ACEI/ARB use (n [%])179 (59)24 (39)0.005